2015
DOI: 10.1016/j.ijsu.2015.08.038
|View full text |Cite
|
Sign up to set email alerts
|

Current status of pig heart xenotransplantation

Abstract: Significant progress in understanding and overcoming cardiac xenograft rejection using a clinically relevant large animal pig-to-baboon model has accelerated in recent years. This advancement is based on improved immune suppression, which attained more effective regulation of B lymphocytes and possibly newer donor genetics. These improvements have enhanced heterotopic cardiac xenograft survival from a few weeks to over 2 years, achieved intrathoracic heterotopic cardiac xenograft survival of 50 days and orthot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
62
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
4
2

Relationship

0
10

Authors

Journals

citations
Cited by 79 publications
(62 citation statements)
references
References 52 publications
0
62
0
Order By: Relevance
“…Blockade of CD40/CD154 costimulatory pathway has emerged as a promising therapeutic modality in allotransplantation, xenotransplantation as well as autoimmune disease models[14, 2527]. Although the treatment with anti-CD154 Ab has proven effective in xenotransplantation[28, 29], anti-CD154 Ab has yielded to antagonistic anti-CD40 Ab in the field of transplantation because of the thrombotic complications[11].…”
Section: Discussionmentioning
confidence: 99%
“…Blockade of CD40/CD154 costimulatory pathway has emerged as a promising therapeutic modality in allotransplantation, xenotransplantation as well as autoimmune disease models[14, 2527]. Although the treatment with anti-CD154 Ab has proven effective in xenotransplantation[28, 29], anti-CD154 Ab has yielded to antagonistic anti-CD40 Ab in the field of transplantation because of the thrombotic complications[11].…”
Section: Discussionmentioning
confidence: 99%
“…Differences in methods for cardiac xenotransplantation, i.e. heterotopic, orthotopic and intra-thoracic heterotopic, have all been well described [20], however, despite heterotopic transplantation having the benefit of unlimited growth in the abdomen as opposed to orthotopic heart transplantation into the mediastinum, the heterotopic abdominal approach is not life-supporting and true orthotopic models have been complicated by an entity known as perioperative cardiac xenograft dysfunction (PCXD) requiring additional investigation, currently ongoing.…”
Section: Short Communicationmentioning
confidence: 99%
“…The maximal survival of a pig-to-NHP orthotopic heart is 57 days. 82 According to the International Society for Heart and Lung Transplantation guidelines, a clinical trial should only be considered when approximately 60% survival of life-supporting pig organs in non-human primates has been achieved for a minimum of 90 days, with at least 10 animals surviving for this minimum period. Furthermore, evidence should suggest that longer survival (>6 months) can be achieved.…”
Section: The Future Of Transplantation Is Xenotransplantation and Itmentioning
confidence: 99%